Last kr755.00 DKK
Change Today +5.00 / 0.67%
Volume 18.9K
ALKB On Other Exchanges
Symbol
Exchange
Copenhagen
OTC US
Berlin
OTC US
As of 11:02 AM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jens Bager

Chief Executive Officer, President and Member of the Board of Management, ALK-Abelló A/S
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 4 different industries.

See Board Relationships
55--

Background*

Mr. Jens Bager has been the Chief Executive Officer and President of Alk-Abelló A/S since 2000. Mr. Bager served as Corporate Manager of Chr. Hansen Holding A/S and served as its President and Chief Executive Officer since August 2005. From 1998 to 2000, he served as an Executive Vice President with responsibility for the Colour Division at Chr. Hansen A/S and Vice President for Corporate Development and Communication of Chr. Hansen Holding A/S from 1993 to 1998. He ...

Read Full Background

Corporate Headquarters*

Bøge Allé 6-8
Hørsholm, -- 2970

Denmark

Phone: 45 45 74 75 76
Fax: 45 45 74 86 07

Board Members Memberships*

2009-N/A
Former Director
2010-Present
Chairman of The Board and Chairman of Nomination & Remuneration Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKB:DC kr755.00 DKK +5.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Christian Chavy Chief Executive Officer, Director, Member of Executive Management Committee, Member of Audit Committee and Member of Strategic & Corporate Development Committee
Stallergenes S.A.
--
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Sanofi
€700.0K
Manuel Llobet Chief Executive Officer and Executive Director
Allergy Therapeutics plc
291.0K GBP
Pierre-Henri Benhamou Co-Founder, Chairman and Chief Executive Officer
DBV Technologies S.A.
€280.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALK-ABELLO A/S, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.